JP2019509715A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509715A5 JP2019509715A5 JP2018534792A JP2018534792A JP2019509715A5 JP 2019509715 A5 JP2019509715 A5 JP 2019509715A5 JP 2018534792 A JP2018534792 A JP 2018534792A JP 2018534792 A JP2018534792 A JP 2018534792A JP 2019509715 A5 JP2019509715 A5 JP 2019509715A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- cells
- administration
- treating
- tumor according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16163557.8 | 2016-04-01 | ||
| EP16163557 | 2016-04-01 | ||
| EP16176185.3 | 2016-06-24 | ||
| EP16176185 | 2016-06-24 | ||
| PCT/EP2017/057679 WO2017167959A1 (en) | 2016-04-01 | 2017-03-31 | Mesenchymal stem cells to enhance anti-tumor activity of immunotherapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019509715A JP2019509715A (ja) | 2019-04-11 |
| JP2019509715A5 true JP2019509715A5 (https=) | 2020-05-07 |
| JP6971986B2 JP6971986B2 (ja) | 2021-11-24 |
Family
ID=58489308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018534792A Active JP6971986B2 (ja) | 2016-04-01 | 2017-03-31 | 免疫療法の抗腫瘍活性を高めるための間葉系幹細胞 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190030152A1 (https=) |
| EP (2) | EP3411473B1 (https=) |
| JP (1) | JP6971986B2 (https=) |
| KR (1) | KR20190003456A (https=) |
| CN (1) | CN108884440A (https=) |
| AU (2) | AU2017242899A1 (https=) |
| CA (1) | CA3008352A1 (https=) |
| ES (1) | ES2823162T3 (https=) |
| PL (1) | PL3411473T3 (https=) |
| WO (1) | WO2017167959A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3059249A1 (en) * | 2017-04-07 | 2018-10-11 | Cynata Therapeutics Limited | Method for treating a side effect of chimeric antigen receptor (car) t cell therapy |
| US20200323922A1 (en) * | 2017-06-16 | 2020-10-15 | Cynata Therapeutics Limited | Method for treating a side effect of immunotherapy |
| US12016882B2 (en) | 2017-11-22 | 2024-06-25 | The Brigham And Women's Hospital, Inc. | Method of treating glioblastoma multiforme |
| US20220133791A1 (en) * | 2019-01-23 | 2022-05-05 | Miltenyi Biotec B.V. & Co. KG | A Combination of compositions for elimination and enhanced engraftment of hematopoietic stem cells in the bone marrow of a subject |
| AU2021217373A1 (en) * | 2020-02-05 | 2022-08-04 | Neoimmunetech, Inc. | Method of treating a solid tumor with a combination of an IL-7 protein and CAR-bearing immune cells |
| US20240082398A1 (en) * | 2021-01-15 | 2024-03-14 | City Of Hope | Methods of preparing and expanding type i innate lymphoid cells and therapeutic uses thereof |
| CN112980888B (zh) * | 2021-02-22 | 2023-04-14 | 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） | 分泌il-6抗体/cd20抗体的间充质干细胞、构建方法及其应用 |
| IL312434A (en) * | 2021-11-01 | 2024-06-01 | Mam Holdings Of West Florida L L C | Mesenchymal stem cells for the prevention and targeted treatment of cancer and other diseases |
| EP4180049A1 (en) * | 2021-11-16 | 2023-05-17 | Ostravska univerzita | Therapeutic composition for cancer treatment |
| US20230218671A1 (en) * | 2022-01-10 | 2023-07-13 | Creative Medical Technologies, Inc. | Chimeric antigen receptor regenerative gamma delta t cells |
| AU2023282907A1 (en) * | 2022-06-09 | 2024-11-14 | Kite Pharma, Inc. | Methods of preparing lymphocytes for cell therapy |
| CN115463155B (zh) * | 2022-11-01 | 2023-05-23 | 卡瑞济(北京)生命科技有限公司 | 间充质干细胞的用途 |
| WO2025225578A1 (ja) * | 2024-04-25 | 2025-10-30 | ロート製薬株式会社 | 癌治療剤 |
| WO2025264721A1 (en) * | 2024-06-17 | 2025-12-26 | Immorta Bio, Inc. | Enhancement of regenerative activity by inactivation of senescent cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1757703A3 (en) | 2005-08-24 | 2007-12-05 | Medizinische Hochschule Hannover | Self-inactivating retroviral vector |
| KR101022401B1 (ko) * | 2005-09-29 | 2011-03-15 | 아주대학교산학협력단 | 자살유전자를 발현하는 중간엽 줄기세포를 포함하는 암치료용 조성물 |
| BRPI0811906A2 (pt) * | 2007-05-24 | 2014-11-18 | Apceth Gmbh & Co Kg | Composições e métodos relacionados a célula-tronco cd34 |
| US8557578B2 (en) | 2009-12-23 | 2013-10-15 | Apceth Gmbh & Co. Kg | Expansion medium for CD34-negative stem cells |
| CN102641298B (zh) * | 2012-05-15 | 2014-03-05 | 祁岩超 | 一种预防和治疗肿瘤的效应细胞组合及其制备方法 |
| WO2014087217A1 (en) * | 2012-12-03 | 2014-06-12 | Subhadra Dravida | Allogenic mesendritic vector for ovarian cancer |
| WO2014100857A1 (en) * | 2012-12-24 | 2014-07-03 | Cell Ideas Pty Ltd | Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
| CN106659742B (zh) * | 2014-08-18 | 2021-09-03 | 埃普塞斯有限责任两合公司 | 表达免疫应答刺激细胞因子以吸引和/或激活免疫细胞的基因修饰间充质干细胞 |
| TW201619133A (zh) * | 2014-08-21 | 2016-06-01 | 裘拉德製藥私人有限公司 | 新穎亞氨腈（ｉｍｉｎｏｎｉｔｒｉｌｅ）衍生物 |
-
2017
- 2017-03-31 PL PL17715658T patent/PL3411473T3/pl unknown
- 2017-03-31 CN CN201780016729.XA patent/CN108884440A/zh active Pending
- 2017-03-31 CA CA3008352A patent/CA3008352A1/en active Pending
- 2017-03-31 EP EP17715658.5A patent/EP3411473B1/en active Active
- 2017-03-31 WO PCT/EP2017/057679 patent/WO2017167959A1/en not_active Ceased
- 2017-03-31 US US16/081,010 patent/US20190030152A1/en not_active Abandoned
- 2017-03-31 KR KR1020187021245A patent/KR20190003456A/ko not_active Withdrawn
- 2017-03-31 AU AU2017242899A patent/AU2017242899A1/en not_active Abandoned
- 2017-03-31 ES ES17715658T patent/ES2823162T3/es active Active
- 2017-03-31 EP EP20177392.6A patent/EP3730607A1/en not_active Withdrawn
- 2017-03-31 JP JP2018534792A patent/JP6971986B2/ja active Active
-
2022
- 2022-10-25 US US18/049,408 patent/US20230063829A1/en active Pending
-
2023
- 2023-09-27 AU AU2023237078A patent/AU2023237078A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019509715A5 (https=) | ||
| Lee et al. | Dendritic cell vaccines: a shift from conventional approach to new generations | |
| Musetti et al. | Nanoparticle-mediated remodeling of the tumor microenvironment to enhance immunotherapy | |
| Liu et al. | Optimizing the manufacturing and antitumour response of CAR T therapy | |
| Restifo et al. | Adoptive immunotherapy for cancer: harnessing the T cell response | |
| Fournier et al. | Trial watch: adoptively transferred cells for anticancer immunotherapy | |
| Vacchelli et al. | Trial Watch—Immunostimulation with cytokines in cancer therapy | |
| Ben Khelil et al. | Harnessing antitumor CD4+ T cells for cancer immunotherapy | |
| Rivera Vargas et al. | TH9 cells in anti-tumor immunity | |
| Matsuo et al. | Recent progress in dendritic cell-based cancer immunotherapy | |
| JP7413639B2 (ja) | 能動的細胞免疫療法のためのサイトカイン組成物を用いたリンパ球の増殖 | |
| Thomas et al. | Immunotherapy for the treatment of glioblastoma | |
| Ginefra et al. | Innate immune cells and their contribution to T-cell-based immunotherapy | |
| Majchrzak et al. | Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic | |
| Oba et al. | In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models | |
| JP2017525364A5 (https=) | ||
| MX2019001185A (es) | Polipeptidos inmunomoduladores y composiciones y metodos relacionados. | |
| Moschella et al. | Combination strategies for enhancing the efficacy of immunotherapy in cancer patients | |
| Draghiciu et al. | Therapeutic immunization and local low‐dose tumor irradiation, a reinforcing combination | |
| Yang et al. | Dendritic Cell‐Based Immunotherapy Treatment for Glioblastoma Multiforme | |
| EP3656387A3 (en) | Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells | |
| JP2018509163A5 (https=) | ||
| Ogasawara | Wilms’ tumor 1-targeting cancer vaccine: Recent advancements and future perspectives | |
| Ding et al. | Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells | |
| ES2966593T3 (es) | Tratamiento del cáncer y de enfermedades autoinmunitarias e inflamatorias |